On March 10, 2026, the Las Vegas Raiders announced that the Baltimore Ravens had “backed out” of a trade that would have sent All-Pro defensive end Maxx Crosby to Baltimore in exchange for two first-round picks. League sources told ESPN the decision followed medical concerns flagged during Crosby’s physical, a step required before trades become official at the start of the new league year Wednesday at 4 p.m. ET. The move leaves the Raiders scrambling after heavy free-agent spending and raises immediate questions about Baltimore’s pass rush plans and Crosby’s health status.
Key Takeaways
- Raiders announced March 10, 2026 that the Ravens withdrew from a deal to acquire Maxx Crosby in exchange for two first-round picks.
- ESPN sources reported the Ravens’ decision stemmed from medical issues identified during Crosby’s physical; trades are contingent on passing physicals and become official at 4 p.m. ET on the new league-year start.
- Las Vegas recently used significant cap space on free agents, including Tyler Linderbaum (3 years, $81M; $60M guaranteed) and signings for Quay Walker, Nakobe Dean, Kwity Paye, Eric Stokes, Malcolm Koonce, and Jalen Nailor.
- The Raiders had already acquired Baltimore’s 14th overall pick in the April draft plus a 2027 first-rounder the previous Friday, a move that would have ended Crosby’s seven-year Raiders tenure.
- Crosby had surgery in January to repair a torn meniscus in his left knee after playing through the injury late in the season; he posted farewell content for Las Vegas and said he was in Baltimore days after the trade reports.
- Baltimore has rescinded deals previously over failed physicals (1997 Brock Marion, 2018 Ryan Grant, 2020 Michael Brockers), underlining a history of medical caution by the franchise.
- Baltimore recorded 30 sacks last season, tied for the second fewest in team history, underscoring why the Crosby move was a strategic priority.
Background
The agreed-upon trade surfaced amid the NFL free-agency window and the final hours before the new league year. The Raiders, after a period of aggressive spending, appeared prepared to part with significant draft capital for an elite pass rusher. Baltimore, which finished a season with one of its weakest pass rush totals in decades, had been pursuing help off the edge to complement its defense.
Medical clearances are standard preconditions for finalized trades. Historically, the Ravens have declined to complete deals after independent or team physicians identify concerning findings; the club’s past actions in 1997, 2018 and 2020 show a pattern of rescinding contracts on medical grounds. For the Raiders, who had already reshaped their roster through several high-value free-agent contracts, the sudden reversal creates roster-building and cap-management complications.
Main Event
The Raiders’ March 10 statement said the Ravens “backed out” of the Crosby trade; ESPN sources added that medical issues discovered during Crosby’s physical prompted Baltimore’s decision. League rules make trades conditional on players passing physicals and on formal processing at the start of the new league year—4 p.m. ET on Wednesday—so teams often complete paperwork contingent on clearance.
Las Vegas planned an internal meeting that night to determine next steps, according to sources. The club has already committed large sums to outside free agents—most notably a reported three-year, $81 million deal for center Tyler Linderbaum with $60 million guaranteed—and now faces the prospect of reallocating resources if Crosby cannot be moved or returns to their roster.
Maxx Crosby underwent left-knee meniscus surgery in January after playing through the issue; team sources say he had been aware of the need for surgery in the fall and was shut down for the final two games of the season. Crosby posted a 13-minute farewell video to Las Vegas and, days later, an Instagram update indicating he was in Baltimore and eager to start the next chapter.
Sources indicated the Raiders are open to repackaging Crosby in a different deal, though one reported likely suitor—the Dallas Cowboys—was not expected to re-enter talks immediately because they recently restructured their own acquisitions, including a trade for Rashan Gary. Whether another team will pursue Crosby will depend on medical rechecks and how the Raiders choose to address their roster and cap.
Analysis & Implications
Short term, the most immediate effect falls on Las Vegas. Having spent heavily in free agency and traded future draft capital for the 14th pick and a 2027 first-rounder, the Raiders now must reconcile a roster plan that assumed Crosby’s departure and Baltimore’s cooperation. If Crosby returns to Las Vegas, the team must decide whether to retain him, find a new trade partner or negotiate an injury settlement if applicable.
For Baltimore, rescinding the deal preserves draft capital but leaves a glaring personnel gap. With 30 sacks last season—tied for the second fewest in franchise history—the Ravens still need edge-rushing help. The team faces a narrower free-agent market and must weigh continuing medical caution against roster needs as the draft approaches.
League-wide, the episode highlights how medical evaluations can change the calculus of high-profile trades even after public announcements and social-media posts. Teams increasingly rely on second-opinion and independent evaluations; when differences arise, contracts can be voided, elevating the role of medical transparency and risk assessment in roster construction.
Longer-term implications will hinge on the specifics of Crosby’s medical report. If concerns are reparable or manageable, a revised trade or a return to play could follow. If doctors identify a structural risk that limits long-term availability, the financial and draft capital investments made by both teams in the surrounding moves will be scrutinized by front offices and analysts alike.
Comparison & Data
| Item | Relevant figure |
|---|---|
| Ravens sacks (2025 season) | 30 (tied 2nd fewest in team history) |
| Raiders recent Linderbaum deal | 3 yrs, $81M; $60M guaranteed |
| Other Raiders signings (notable) | Walker $40.5M, Dean $36M, Paye $48M, Stokes $30M, Koonce $11M, Nailor $35M (all multi/one-year) |
The table contextualizes why Baltimore pursued a proven pass rusher and why Las Vegas believed swapping picks for Crosby made strategic sense. With only 30 sacks, the Ravens were among the league’s least-productive pass-rushing units; acquiring Crosby would have immediately upgraded that metric. Conversely, the Raiders’ recent guaranteed-money commitments reduce their financial flexibility to absorb Crosby if the trade collapses or must be restructured.
Reactions & Quotes
“The Ravens have backed out of the agreement to acquire Maxx Crosby,”
Las Vegas Raiders (team announcement)
The Raiders’ terse notice confirmed the reversal but provided no medical specifics. Team officials planned an internal discussion to determine their approach, reflecting the operational uncertainty teams face in the wake of a failed conditional trade.
“I know there’s no guarantees in this, but I’m going to give everything in my heart and soul to bring a championship to Baltimore,”
Maxx Crosby (social post)
Crosby’s public message, posted before news of the voided trade, emphasized his intent and frustration at the season’s end when he was shut down. His social posts complicate optics for all parties, as fans and media had already absorbed the narrative of a pending move.
“We’re open to repackaging a Crosby trade,”
Team source (unidentified)
League sources say the Raiders have left the door open to alternative trade structures; any follow-up deal will hinge on additional medical evaluations and which teams are willing to accept the risk.
Unconfirmed
- The precise medical findings that prompted Baltimore’s decision have not been disclosed publicly and remain unconfirmed.
- It is unclear whether the Raiders and Ravens will reopen trade discussions or if a third team will finalize a deal for Crosby.
- Reports that the Dallas Cowboys will not pursue Crosby again are based on sources and have not been formally announced by Dallas.
Bottom Line
The collapse of the Crosby trade underscores how medical evaluations can abruptly alter NFL roster plans even after high-profile agreements and player statements. For Las Vegas, the immediate challenge is practical: manage the roster and cap after committing large sums to free agents while holding onto or rerouting a marquee defensive asset.
For Baltimore, the choice to prioritize medical caution preserves draft capital but prolongs the need to address a thin pass rush. Both teams now face timing pressure—free agency moves and draft preparation continue—so medical clarity and quick front-office decisions will determine whether this episode remains a temporary setback or reshapes each club’s offseason trajectory.